Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis [ 2017 - 2021 ]

Research Grant

Researchers: Prof Stephen Stick (Principal investigator) ,  A/Pr Robert Trengove ,  Prof Graham Hall ,  Prof Harm Tiddens ,  Prof Sarath Ranganathan

Brief description Sensitive and reliable tests are required to monitor lung disease severity in cystic fibrosis. A number of potential methods have emerged in recent years. We will investigate how these tests track an acute episode of lung disease and determine whether, following a typical course of treatment, there is evidence of residual damage that contributes to overall progression of lung disease.

Funding Amount $AUD 1,057,296.15

Funding Scheme Project Grants

Notes Standard Project Grant